NCT02875418

Brief Summary

Background: Identification and measurement of uterine contractions throughout pregnancy and labor is crucial to the well being of both mother and fetus. Prematurity is one of the major causes for adverse pregnancy outcomes, and clinical decision-making often relies on uterine frequency as recorded by a tocodynamometer, as well as on other methods including sonographic cervical length, pelvic examination. Objective: To show that the use of the EUM in preterm labor is effective in establishing true preterm labor.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Sep 2016

Typical duration for phase_3

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 23, 2016

Completed
9 days until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

August 23, 2016

Status Verified

August 1, 2016

Enrollment Period

3 years

First QC Date

August 18, 2016

Last Update Submit

August 18, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of preterm deliveries

    Week of gestation will be documented.

    4 month

Study Arms (1)

EUM and tocodynamometry

EXPERIMENTAL

Pregnant women with gestational age 24+0/7 to 33+6/7 weeks of gestation and contractions, cramping, pelvic pressure or backache.

Device: EUMDevice: Tocodynamometry

Interventions

EUMDEVICE

STUDY DESIGN 1. Explanation regarding the study and assessing eligibility criteria. 2. Signing an informed consent. 3. Recording of uterine contractions by both EUM and tocodynamometry. A correlation between EUM and tocodynamometry will be calculated. For the purpose of this study, a positive EUM or tocodynamometry will be defined as 3 at least 3 contractions in 30 minutes.

EUM and tocodynamometry

STUDY DESIGN 1. Explanation regarding the study and assessing eligibility criteria. 2. Signing an informed consent. 3. Recording of uterine contractions by both EUM and tocodynamometry. A correlation between EUM and tocodynamometry will be calculated. For the purpose of this study, a positive EUM or tocodynamometry will be defined as 3 at least 3 contractions in 30 minutes.

EUM and tocodynamometry

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Gestational age 24+0/7 to 33+6/7 weeks of gestation.
  • Maternal age \> 18 years.
  • Contractions, cramping, pelvic pressure or backache.
  • Reactive fetal heart rate monitoring at enrollment.
  • Subjects are willing and able to comply with the requirements of the protocol.
  • Fully understand all elements of the study, and have signed and dated, the written informed consent form before initiation of protocol-specified procedures.

You may not qualify if:

  • Refusal to participate.
  • Maternal age \< 18 years.
  • Woman with implanted electronic device of any kind.
  • Woman with allergy to silver.
  • Irritated skin or open wound.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Uterine Monitoring

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Obstetrical and GynecologicalDiagnostic Techniques and ProceduresDiagnosisMonitoring, Physiologic

Study Officials

  • yariv yogev, professor

    Tel Aviv Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

yariv yogev, professor

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2016

First Posted

August 23, 2016

Study Start

September 1, 2016

Primary Completion

September 1, 2019

Study Completion

September 1, 2019

Last Updated

August 23, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share